Drug Therapy, Other

Contributing journals to this collection:
JAMA & Archives Journals

Citations 381-390 of 2201 total displayed.

Past content

Editorials
Aspirin and Secondary Prevention in Peripheral Artery Disease: A Perspective for the Early 21st Century

Mary McGrae McDermott; Michael H. Criqui
JAMA 2009; 301: 1927-1928. [Extract] [Full text] [PDF]  

Editorials
Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299(14):1669-1677.

Catherine D. DeAngelis; Phil B. Fontanarosa
JAMA 2009; 301: 1931. [Extract] [Full text] [PDF] [ RETRACTED ARTICLE ]  

Editorials
Time for the Medical Profession to Act: New Policies Needed Now on Interactions Between Pharmaceutical Companies and Physicians

Philip Greenland
Arch Intern Med 2009; 169: 829-831. [Extract] [Full text] [PDF]  

Special Articles
ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses

Jackson T. Wright Jr; Jeffrey L. Probstfield; William C. Cushman; Sara L. Pressel; Jeffrey A. Cutler; Barry R. Davis; Paula T. Einhorn; Mahboob Rahman; Paul K. Whelton; Charles E. Ford; L. Julian Haywood; Karen L. Margolis; Suzanne Oparil; Henry R. Black; Michael H. Alderman; for the ALLHAT Collaborative Research Group
Arch Intern Med 2009; 169: 832-842. [Abstract] [Full text] [PDF]  

Original Investigations
Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences

David Grande; Dominick L. Frosch; Andrew W. Perkins; Barbara E. Kahn
Arch Intern Med 2009; 169: 887-893. [Abstract] [Full text] [PDF]  

Original Investigations
A Comprehensive Pharmacist Intervention to Reduce Morbidity in Patients 80 Years or Older: A Randomized Controlled Trial

Ulrika Gillespie; Anna Alassaad; Dan Henrohn; Hans Garmo; Margareta Hammarlund-Udenaes; Henrik Toss; Åsa Kettis-Lindblad; Håkan Melhus; Claes Mörlin
Arch Intern Med 2009; 169: 894-900. [Abstract] [Full text] [PDF]  

Editor's Correspondence
Cost-effectiveness of Strategies for Monitoring the Response to Antiretroviral Therapy in Resource-Limited Settings—Reply

Eran Bendavid; Douglas K. Owens
Arch Intern Med 2009; 169: 904-a-905-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Cost-effectiveness of Strategies for Monitoring the Response to Antiretroviral Therapy in Resource-Limited Settings

Andrew N. Phillips; Charles Gilks, DPhil; Jens D. Lundgren
Arch Intern Med 2009; 169: 904. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Guideline Supports Long-term Use of Medication to Lower Prostate Cancer Risk

Mike Mitka
JAMA 2009; 301: 1753-1754. [Extract] [Full text] [PDF]  

Lab Reports
Muscular Dystrophy Patch

Bridget M. Kuehn
JAMA 2009; 301: 1758-b. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221